Linked linear amplification of nucleic acids

• US 6,027,923 A
• Filed: 04/02/1997
• Issued: 02/22/2000
• Est. Priority Date: 07/23/1993
• Status: Expired due to Fees

• Current Assignee: Bio-Rad Laboratories Incorporated
• Original Assignee: Bio-Rad Laboratories Incorporated
• Inventors: Wallace, Robert Bruce
• Primary Examiner(s): Houtteman, Scott W.
• Application Number:
  US08/826,532
• Time in Patent Office: 1,056 Days
• Field of Search: 435/6, 435/91.2
• US Class Current: 435/91.2
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 2521/301 Endonuclease
• CPC Class Codes: C12Q 2525/113 incorporating modified backbone
• CPC Class Codes: C12Q 2525/191 incorporating an adaptor

Abstract

The extensive synthesis ("amplification") of a nucleic acid sequence of interest is attained through a linked series of multi-cycle primer extension reactions (LLA). The primers used in each of the primer extension reactions of the process contain non-replicable elements that halt nucleic acid synthesis and thereby prevent the synthesized molecules from serving as templates in subsequent cycles. Synthesized molecules accumulate during primer extension in a mathematically linear fashion, thereby rendering the process relatively insensitive to contaminating nucleic acids. Multiple primer sets are employed, thereby ensuring the accumulation of a large number of copies of the nucleic acid sequence of interest. The invention also provides for the detection of an amplified nucleic acid sequence of interest, as well as reagent kits for carrying out the reaction.

Claims

1. A process for amplifying a nucleic acid sequence of interest contained within a nucleic acid comprised of a first strand and a second strand that is complementary to the first strand, the process comprising:

(a) contacting each of the first and second strands with a primer that contains a non-replicable element and/or a cleavable element, under conditions such that first generation primer extension products are produced using said strands as templates, and wherein the primer for the first strand is selected such that a first generation primer extension product produced using the first strand as a template, when separated from the first strand, can serve as a template for synthesis of a second generation primer extension product of the primer for the second strand;

(b) separating the first generation primer extension products from their respective templates to produce single-stranded molecules; and

(c) treating the first generation primer extension products with the primers of step (a) under conditions such that second generation primer extension products are produced using the first generation primer extension products as templates;

wherein the second generation primer extension products contain at least a portion of the sequence of the nucleic acid sequence of interest and no more than an insufficient portion of the binding site for the primer producing said first generation primer extension products.

2. A process according to claim 1 further comprising separating the second generation primer extension products generated from their respective templates to produce single-stranded molecules.

3. A process according to claim 1 wherein step (c) is repeated at least once.

4. The process of claim 1 wherein the primer contains a non-replicable element.

5. A process according to claim 1 wherein the non-replicable element and/or cleavable element is not located at the terminal residue of any of said primers.

6. A process according to claim 4 wherein the non-replicable element is a derivative of a deoxyribonucleotide.

7. A process according to claim 4 wherein the non-replicable element is a derivative of a ribonucleotide.

8. A process according to claim 6 wherein the non-replicable element is a residue of 1,3-propane diol.

9. A process according to claim 6 wherein the non-replicable element is a residue of 1,4-anhydro-2-deoxy-D-ribitol.

10. A process according to claim 1 further comprising the step of treating the second generation primer extension products with primers containing a non-replicable element under conditions such that primer extension products are synthesized utilizing the second generation primer extension products as templates.

32. A process according to claim 1 wherein the nucleic acid sequence contains a polymorphic site associated with a genetic disease, and each of said primers are selected so as to prime nucleic acid synthesis only in the presence or only in the absence of said disease state.

33. A process according to claim 32, wherein said genetic disease is sickle cell anemia.

34. A process according to claim 1 further comprising detecting the presence or absence of an amplified nucleic acid sequence of interest.

37. The process of claim 1 wherein the primer contains a cleavable element.

38. The process of claim 37 wherein the cleavable element is a ribonucleoside.

39. The process of claim 38 wherein the first generation primer extension product is cleaved by treating said product with ribonuclease.

11. A process for amplifying a nucleic acid sequence of interest contained within complementary nucleic acid strands, comprising:

(a) contacting the strands with first primers and second primers, each of said first and second primers containing a non-replicable element and/or a cleavable element, under conditions such that a first generation primer extension product is synthesized from said first and second primers using the strands as templates, and wherein the first and second primers are selected such that the first generation primer extension products, when separated from their templates, can serve as templates for synthesis of second generation primer extension products of the first and second primers;

(b) separating the first generation primer extension products from their respective templates to produce single-stranded molecules; and

(c) treating the first generation primer extension products with the first and second primers under conditions such that second generation primer extension products are synthesized using the first generation primer extension products as templates;

wherein the second generation primer extension products contain at least a portion of the sequence of the nucleic acid sequence of interest and no more than an insufficient portion of the binding site for either of said first and second primers for producing said first generation primer extension products.

12. A process according to claim 11 further comprising separating the primer extension products generated from step (c) to produce single-stranded molecules.

13. A process according to claim 11 wherein step (c) is repeated at least once.

14. A process according to claim 11 wherein the non-replicable element and/or cleavable element is not located at the terminal residue of any of said primers.

15. The process of claim 11 wherein the primer contains a non-replicable element.

16. A process according to claim 15 wherein the non-replicable element is a derivative of a deoxyribonucleotide.

17. A process according to claim 15 wherein the non-replicable element is a derivative of a ribonucleotide.

18. A process according to claim 16 wherein the non-replicable element is a residue of 1,3-propane diol.

19. A process according to claim 16 wherein the non-replicable element is a residue of 1,4-anhydro-2-deoxy-D-ribitol.

20. A process according to claim 11 further comprising treating the second generation primer extension products of said second primers with third primers, each of said third primers containing a non-replicable element, under conditions such that third-primer extension products are formed utilizing the second generation primer extension products of said second primers as templates.

21. A process according to claim 11 wherein each of said strands contains a primer binding site for a first primer and a primer binding site for a second primer, the primer binding site for the first primer being 3'"'"' of the primer binding site for the second primer.

35. A process according to claim 11 further comprising detecting the presence or absence of an amplified nucleic acid sequence of interest.

40. The process of claim 11 wherein the primer contains a cleavable element.

41. The process of claim 40 wherein the cleavable element is a ribonucleoside.

42. The process of claim 41 wherein the first generation primer extension product is cleaved by treating said product with ribonuclease.

22. A process for amplifying a nucleic acid sequence of interest contained within complementary first and second nucleic acid strands, comprising:

(a) contacting the first and second strands with first primers and second primers, each of said first and second primers containing a non-replicable element and/or a non-cleavable element, under a first set of primer extension reaction conditions such that first generation primer extension products are produced from the first primers, and not from the second primers, using the first and second strands as templates, and wherein the first primers are selected such that a first generation primer extension product from this step, when separated from its template, can serve as a template for synthesis of a second generation extension product of the first primer for the complement of said strand;

(b) separating the first generation primer extension products from their respective templates to produce single-stranded molecules;

(c) treating the first generation primer extension products with the primers of step (a) under conditions such that second generation primer extension products are generated using first generation primer extension products as templates;

wherein the second generation primer extension products contain at least a portion of the sequence of the nucleic acid sequence of interest and no more than an insufficient portion of the binding site for either of said first and second primers for producing said first generation primer extension products

(d) separating the second generation primer extension products from their templates to produce single-stranded molecules;

(e) repeating steps (c) and (d) at least once; and

(f) subjecting the reaction mixture of step (e) to a second set of primer extension reaction conditions such that primer extension products are synthesized from said second primers using second generation primer extension products as templates.

23. A process according to claim 22 wherein said first set of primer extension reaction conditions are more stringent than said second set of primer extension reaction conditions.

24. A process according to claim 22 wherein said first set of conditions comprises a higher temperature than said second set of conditions.

25. A process according to claim 22 wherein the non-replicable element and/or cleavable element is not located at the terminal residue of any of said primers.

26. The process of claim 22 wherein the primer contains a non-replicable element.

27. A process according to claim 26 wherein the non-replicable element is a derivative of a deoxyribonucleotide.

28. A process according to claim 26 wherein the non-replicable element is a derivative of a ribonucleotide.

29. A process according to claim 27 wherein the non-replicable element is a residue of 1,3-propane diol.

30. A process according to claim 27 wherein the non-replicable element is a residue of 1,4-anhydro-2-deoxy-D-ribitol.

31. A process according to claim 22 wherein each of said strands contains a primer binding site for a first primer and a primer binding site for a second primer, the primer binding site for the first primer being 3'"'"' of the primer binding site for the second primer.

36. A process according to claim 22 further comprising detecting the presence or absence of an amplified nucleic acid sequence of interest.

43. The process of claim 26 wherein the primer contains a cleavable element.

44. The process of claim 43 wherein the cleavable element is a ribonucleoside.

45. The process of claim 44 wherein the first generation primer extension product is cleaved by treating said product with ribonuclease.